The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells-Reference-Cited by-同舟云学术

The inhibition of PI3K and NFκB promoted curcumin-induced cell cycle arrest at G2/M via altering polyamine metabolism in Bcl-2 overexpressing MCF-7 breast cancer cells

Published:2016-02 Issue: Volume:77 Page:150-160
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Berrak Özge,Akkoç Yunus^ORCID,Arısan Elif Damla,Çoker-Gürkan Ajda,Obakan-Yerlikaya Pınar,Palavan-Ünsal Narçin

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. RB and cell cycle progression;Giacinti;Oncogene,2006

2. Molecular thanatopsis: a discourse on the BCL2 family and cell death;Yang;Blood,1996

3. Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer;Vaillant;Cancer Cell,2013

4. Curcumin in inflammatory diseases;Shehzad;Biofactors,2013

5. The protective effect of curcumin against the 19kDa Mycobacterium tuberculosis protein-induced inflammation and apoptosis in human macrophages;Li;Mol. Med. Rep.,2014

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management;Cancers;2024-07-18

2. The Combined Impact of Curcumin: Piperine and Sorafenib on microRNAs and Different Pathways in Breast Cancer Cells;Indian Journal of Clinical Biochemistry;2024-04-18

3. Curcumin for Treating Breast Cancer: A Review of Molecular Mechanisms, Combinations with Anticancer Drugs, and Nanosystems;Pharmaceutics;2024-01-05

4. Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway;Journal of Translational Medicine;2024-01-03

5. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives;Biomedicine & Pharmacotherapy;2024-01